“…However, TP53TG1 may act as a tumor suppressor gene or an oncogene in different tumors ( Zhang et al, 2019b ; Lu et al, 2021 ). It functions as an oncogene in pancreatic ductal adenocarcinoma (PDAC), retinoblastoma, and nasopharyngeal carcinoma ( Yuan et al, 2017 ; Zhang et al, 2019b ; Shao et al, 2020 ; Tang et al, 2020 ; Cheng et al, 2021a ; Gao et al, 2021 ; Lu et al, 2021 ; Wang et al, 2021 ). In some other cancers, such as non-small cell lung cancer, hepatocellular carcinoma, gastrointestinal cancer, and cutaneous melanoma, TP53TG1 serves as a cancer suppressor ( Benfodda et al, 2018 ; Xiao et al, 2018 ; Chen et al, 2021 ; Masoumi et al, 2021 ).…”